Literature DB >> 27481056

Clinical and Laboratory Profile of Persons Living with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Histoplasmosis from a Colombian Hospital.

Diego H Caceres1, Angela M Tobón2, Angela Ahlquist Cleveland3, Christina M Scheel3, Dedsy Y Berbesi4, Jesús Ochoa5, Angela Restrepo6, Mary E Brandt3, Tom Chiller3, Beatriz L Gómez7.   

Abstract

Histoplasmosis is common among persons living with human immunodeficiency virus/acquired immune deficiency syndrome (PLWHA) in Latin America, but its diagnosis is difficult and often nonspecific. We conducted prospective screening for histoplasmosis among PLWHA with signs or symptoms suggesting progressive disseminated histoplasmosis (PDH) and hospitalized in Hospital La María in Medellín, Colombia. The study's aim was to obtain a clinical and laboratory profile of PLWHA with PDH. During 3 years (May 2008 to August 2011), we identified 89 PLWHA hospitalized with symptoms suggestive of PDH, of whom 45 (51%) had histoplasmosis. We observed tuberculosis (TB) coinfection in a large proportion of patients with PDH (35%), so all analyses were performed adjusting for this coinfection and, alternatively, excluding histoplasmosis patients with TB. Results showed that the patients with PDH were more likely to have Karnofsky score ≤ 30 (prevalence ratio [PR] = 1.98, 95% confidence interval [CI] = 0.97-4.06), liver compromised with hepatomegaly and/or splenomegaly (PR = 1.77, CI = 1.03-3.06) and elevation in serum of alanine aminotransferase and aspartate aminotransferase to values > 40 mU/mL (PR = 2.06, CI = 1.09-3.88 and PR = 1.53, CI = 0.99-2.35, respectively). Using multiple correspondence analyses, we identified in patients with PDH a profile characterized by the presence of constitutional symptoms, namely weight loss and Karnofsky classification ≤ 30, gastrointestinal manifestations with alteration of liver enzymes and hepatosplenomegaly and/or splenomegaly, skin lesions, and hematological alterations. Study of the profiles is no substitute for laboratory diagnostics, but identifying clinical and laboratory indicators of PLWHA with PDH should allow development of strategies for reducing the time to diagnosis and thus mortality caused by Histoplasma capsulatum. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27481056      PMCID: PMC5062801          DOI: 10.4269/ajtmh.15-0837

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  Factors associated with severe manifestations of histoplasmosis in AIDS.

Authors:  L J Wheat; P Chetchotisakd; B Williams; P Connolly; K Shutt; R Hajjeh
Journal:  Clin Infect Dis       Date:  2000-06-14       Impact factor: 9.079

2.  Risk factors for death in acquired immunodeficiency syndrome-associated disseminated histoplasmosis.

Authors:  Elizabeth de Francesco Daher; Fernando Antonio de Sousa Barros; Geraldo Bezerra da Silva Júnior; Christianne Fernandes Valente Takeda; Rosa Maria Salani Mota; Marúsia Thomaz Ferreira; Julieta Cunha Martins; Soraya Alves Jacinto Oliveira; Oswaldo Augusto Gutiérrez-Adrianzén
Journal:  Am J Trop Med Hyg       Date:  2006-04       Impact factor: 2.345

3.  Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.

Authors:  R A Hajjeh; P G Pappas; H Henderson; D Lancaster; D M Bamberger; K J Skahan; M A Phelan; G Cloud; M Holloway; C A Kauffman; L J Wheat
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

4.  AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana.

Authors:  Florence Huber; Matthieu Nacher; Christine Aznar; Magalie Pierre-Demar; Myriam El Guedj; Tania Vaz; Vincent Vantilcke; Abba Mahamat; Christian Magnien; Elodie Chauvet; Bernard Carme; Pierre Couppié
Journal:  AIDS       Date:  2008-05-31       Impact factor: 4.177

5.  Tuberculosis and histoplasmosis co-infection in AIDS patients.

Authors:  Carlos A Agudelo; Carlos A Restrepo; Diego A Molina; Angela M Tobón; Carol A Kauffman; Carolina Murillo; Angela Restrepo
Journal:  Am J Trop Med Hyg       Date:  2012-11-05       Impact factor: 2.345

6.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

7.  Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil.

Authors:  Delio José Mora; Celso Tadeu Barbosa dos Santos; Mario León Silva-Vergara
Journal:  Mycoses       Date:  2008-03       Impact factor: 4.377

8.  Methodology for definition of yellow fever priority areas, based on environmental variables and multiple correspondence analyses.

Authors:  Eduardo Stramandinoli Moreno; Rita de Cássia Barradas Barata
Journal:  PLoS Negl Trop Dis       Date:  2012-07-03

9.  Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage.

Authors:  Mathieu Nacher; Antoine Adenis; Sigrid Mc Donald; Margarete Do Socorro Mendonca Gomes; Shanti Singh; Ivina Lopes Lima; Rosilene Malcher Leite; Sandra Hermelijn; Merril Wongsokarijo; Marja Van Eer; Silvia Marques Da Silva; Maurimelia Mesquita Da Costa; Marizette Silva; Maria Calvacante; Terezinha do Menino Jesus Silva Leitao; Beatriz L Gómez; Angela Restrepo; Angela Tobon; Cristina E Canteros; Christine Aznar; Denis Blanchet; Vincent Vantilcke; Cyrille Vautrin; Rachida Boukhari; Tom Chiller; Christina Scheel; Angela Ahlquist; Monika Roy; Olivier Lortholary; Bernard Carme; Pierre Couppié; Stephen Vreden
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

Review 10.  Histoplasmosis in HIV-Infected Patients: A Review of New Developments and Remaining Gaps.

Authors:  Antoine A Adenis; Christine Aznar; Pierre Couppié
Journal:  Curr Trop Med Rep       Date:  2014-03-28
View more
  10 in total

1.  High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala.

Authors:  Blanca Samayoa; Monika Roy; Angela Ahlquist Cleveland; Narda Medina; Dalia Lau-Bonilla; Christina M Scheel; Beatriz L Gomez; Tom Chiller; Eduardo Arathoon
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries.

Authors:  Diego H Cáceres; Blanca E Samayoa; Eduardo E Arathoon; Beatriz L Gómez; Narda G Medina; Angela M Tobón; Brenda J Guzmán; Danicela Mercado; Angela Restrepo; Tom Chiller
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

3.  Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador.

Authors:  Diana Forno; Blanca Samayoa; Narda Medina; Eduardo Arathoon; Carlos Rodolfo Mejia; Remei Gordillo; Rolando Cedillos; Jose Rodas; Angela Ahlquist Cleveland; Tom Chiller; Diego H Caceres
Journal:  Mycoses       Date:  2021-09-29       Impact factor: 4.931

Review 4.  Histoplasmosis and Tuberculosis Co-Occurrence in People with Advanced HIV.

Authors:  Diego H Caceres; Audrey Valdes
Journal:  J Fungi (Basel)       Date:  2019-08-09

5.  Loop-mediated Isothermal Amplification and nested PCR of the Internal Transcribed Spacer (ITS) for Histoplasma capsulatum detection.

Authors:  Matheus da Silva Zatti; Thales Domingos Arantes; José Alex Lourenço Fernandes; Mônica Baumgardt Bay; Eveline Pipolo Milan; Georggia Fatima Silva Naliato; Raquel Cordeiro Theodoro
Journal:  PLoS Negl Trop Dis       Date:  2019-08-26

Review 6.  Histoplasmosis overlapping with HIV and tuberculosis in sub-Saharan Africa: challenges and research priorities.

Authors:  Marius Paulin Ngouanom Kuate; Bassey Ewa Ekeng; Richard Kwizera; Christine Mandengue; Felix Bongomin
Journal:  Ther Adv Infect Dis       Date:  2021-04-09

7.  Symptoms in Blastomycosis, Coccidioidomycosis, and Histoplasmosis Versus Other Respiratory Illnesses in Commercially Insured Adult Outpatients-United States, 2016-2017.

Authors:  Kaitlin Benedict; Miwako Kobayashi; Shikha Garg; Tom Chiller; Brendan R Jackson
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

8.  The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia.

Authors:  Diego H Caceres; Ángela M Tobón; Ángela Restrepo; Tom Chiller; Beatriz L Gómez
Journal:  Med Mycol Case Rep       Date:  2018-01-17

9.  Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies.

Authors:  Mathieu Nacher; Denis Blanchet; Felix Bongomin; Arunaloke Chakrabarti; Pierre Couppié; Magalie Demar; David W Denning; Félix Djossou; Loïc Epelboin; Nelesh Govender; Terezinha Leitão; Sigrid Mac Donald; Christine Mandengue; Silvia Helena Marques da Silva; Rita Oladele; Maria Mercedes Panizo; Alessandro Pasqualotto; Ruth Ramos; Subramanian Swaminathan; Juan Luis Rodriguez-Tudela; Stephen Vreden; Rosely Zancopé-Oliveira; Antoine Adenis
Journal:  PLoS Negl Trop Dis       Date:  2018-10-19

10.  A Simple Predictive Score to Distinguish between Disseminated Histoplasmosis and Tuberculosis in Patients with HIV.

Authors:  Mathieu Nacher; Kinan Drak Alsibai; Loïc Epelboin; Philippe Abboud; Frédégonde About; Magalie Demar; Félix Djossou; Romain Blaizot; Maylis Douine; Nadia Sabbah; Nicolas Vignier; Leila Adriouch; Aude Lucarelli; Mathilde Boutrou; Pierre Couppié; Antoine Adenis
Journal:  J Fungi (Basel)       Date:  2021-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.